We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rws Holdings Plc | LSE:RWS | London | Ordinary Share | GB00BVFCZV34 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.60 | 1.41% | 187.60 | 185.90 | 186.80 | 190.00 | 183.90 | 186.00 | 564,047 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 733.8M | -27.7M | -0.0738 | -25.19 | 697.44M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/4/2017 14:54 | picked up a few more cheap ones today | phillis | |
03/4/2017 07:40 | wait for a bullish trading statement shortly | phillis | |
15/3/2017 21:24 | been here before ... what's changed? When you owe shares in a quality company, time is your friend | jg88721 | |
15/3/2017 18:28 | lifeless and a relentless move south without any sign of reversing? | insideryou | |
13/3/2017 08:12 | Dunno, jg.. I just reported the link. Paucity of real data, as you observed earlier. I agree with your opinion that it is a matter of trust in the management. I have only returned to watching RWS after the recent share price drift and have bought a first holding, so I haven't had chance to gain the confidence you have. apad | apad | |
12/3/2017 22:50 | Google Luz Inc. From the website, under services overview. Capacity and Scalability Over 1,500 life science linguists, editors/proofreaders | redartbmud | |
12/3/2017 21:32 | surely they haven't lost 80 staff, apad? LUZ has been growing quickly according to its revenue numbers, so very unlikely staff numbers are reducing. Could some people be contractors and one number (100) is of permanents only, the other (180)includes temporary and contracting staff? The revenue number you quote seems about right - RWS said LUZ had revenue of 23.7m in 2015 (and 29.2 in 2016, from 21.2 in 2014). As I said previously, I wished RWS released more info on LUZ. We'll know more when we say subsequent earnings releases. In the interim, we just have to trust mgmt. to have got this right. I do, but I'd still like to know more! | jg88721 | |
12/3/2017 12:15 | head count in rns is 100, I believe. Interesting discrepency. apad | apad | |
12/3/2017 12:13 | Spoke too soon! | phillis | |
11/3/2017 08:15 | Looks like 25m revenue in 2016. Glassdoor reports the exodus of experienced staff in 2016. New directors appointed in 2016. apad LUZ, Inc. Location San Francisco, CA Revenue $25m Total Funding $– Founded 1994 Headcount 180 Stage private Company Website luz.com/ linkedin.com/LUZ, Inc. | apad | |
10/3/2017 19:28 | but I'm already here, Phillis | jg88721 | |
10/3/2017 09:36 | jg well better to keep the nutters away dont you think? | phillis | |
10/3/2017 09:29 | agreed Phillis. I've held for over a decade too, and plan to hold for another one! For an outstanding company, never ceases to amaze that this is such a quiet board! | jg88721 | |
10/3/2017 09:24 | this is a wonderful stock and i have been a fan for over a decade looking forward to a trading update in early April last comment from the AGM RNS "As a result, profits for the first quarter were comfortably ahead of management's expectations" The share price is a bit flat following the placement activity so a good time for some top up IHT free in an ISA to boot | phillis | |
15/2/2017 19:45 | And Telegraph's Questor too. | jeffian | |
15/2/2017 18:46 | Tipped in The Times today - 'strong track record on growth and acquisitions'. | alphabeta4 | |
15/2/2017 18:17 | thanks for posting Andrew | jg88721 | |
15/2/2017 09:14 | Bought into these last night- technically looking very strong | essential | |
15/2/2017 08:22 | OK with me too Andrew | phillis | |
14/2/2017 22:30 | Well, there we have it from the horses mouth (apologies to AB who I have met and has only two legs). Whatever advantages a full listing might appear to confer, it's clear to me that one of the attractions of companies like RWS is that management and shareholders interests are perfectly aligned when it comes to IHT. | alter ego | |
14/2/2017 17:36 | Hi jg and alter ego, thanks for your replies. Seems a shame if they don't fully list, perhaps a bit of downside from having a significant holder who in theory should be working in all shareholder interests albeit I would gather lots are happy with how well their investment has done here and will be keen to keep management on board. It would hopefully expand the amount of information we get too. Hey ho. | alphabeta4 | |
14/2/2017 17:26 | I confirm that I and more than 20% of our other shareholders are very interested in IHT/BPR relief, so a move to the Full List is highly unlikely in the near term.We like being a Top 10 Aim listed company. | brode2 | |
14/2/2017 14:28 | Stockopedia's Graham Neary likes the results - RWS Holdings (LON:RWS) Share price: 354p (+4.5%) No. shares: 215.8m Market cap: £764m Acquisition and Placing AGM Statement A strong statement to open today's news: "Since [30 September 2016], the Group has traded strongly with underlying growth bolstered by favourable currency movements. We are achieving meaningful new client wins in both of our core activities, intellectual property and Life Sciences and increased levels of business from a number of our established clients. As a result, profits for the first quarter were comfortably ahead of management's expectations. I must admit that I haven't studied this company before, but it sounds quite interesting: RWS Group is internationally renowned for providing high-quality translation, intellectual property and language support services, which we deliver through our in-house translators, searchers and technical experts. Excuse my ramblings, but shouldn't IP translation and search be secular growth industries in today's economy? RWS has had 13 successive years of growth in sales & profits - is that a mark of their individual brilliance as a company, or is it mostly to do with growth trends in their markets? I'd be curious to learn more. Anyway, today's $82.5 million acquisition is for the life sciences division: The Acquisition strengthens the Group's leading position in global Life Sciences both in the US and Europe, building upon and complementing the October 2015 acquisition of Corporate Translations Inc. ("CTi") and creating a full service offering. It also enhances the platform for expansion into Asia, building on the existing Chinese and Japanese presence of other RWS divisions. The Acquisition also brings strong cross-selling opportunities through enhanced exposure to the important West Coast patent market and potentially bringing new clients to the wider Group. It also provides diversification to the Group (including currency) and further visibility across the value chain. It's good to see a combination of funding sources being used: the placing, cash and a bank term loan, with most of it coming the placing (worth $50 million at GBPUSD = 1.25). The Value Rank is not a big fan of this stock, at a PE ratio of 27x. Without going into it in any more detail, it wouldn't surprise me if this stock was in fact decent value here - specialist, niche services with huge growth momentum behind them are often worth paying up for. | martinthebrave |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions